Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
We cover the top budgeting pitfalls and simple methods to prevent them, helping you maintain accuracy and momentum in your plan.
17,089 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Tom Zschach, who led SWIFT's digital asset strategy for six years, publicly dismissed XRP partnership rumors on July ...
As gig work grows, Solo 401K options offer a powerful retirement path for Uber and DoorDash drivers. Yet many workers...
The space-tech IPO has hit a snag, with shares slipping below the initial price. This guide breaks down what the drop...
SpaceX joining the Nasdaq-100 would be a major headline, but the real questions are about risk, weighting, and portfo...
IBM is attracting fresh investor attention as its AI infrastructure strategy gains traction. Arvind Krishna’s reshape...
Apple has chosen caution in the AI race, trading near its highs as investors bet on durability and profits over rapid...
For years, SK Hynix has traded at a discount to Micron. This article explains why the gap exists, what could close it...
CleanSpark stock surged after disclosing a $6.6 billion, 20-year data center lease in Georgia, underscoring a shift f...
Choosing between VEA and NZAC boils down to your priority: broad diversification in developed markets or a climate-al...
A controversial proposal has sparked a fierce debate among developers, miners, and industry leaders. This article unp...
TSMC is set to release Q2 results on July 16, 2026 as investors weigh a record profit jump and the path forward for A...